LGI4 binds ADAM22,23,11

Stable Identifier
R-HSA-5682709
Type
Reaction [binding]
Species
Homo sapiens
Compartment
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

Leucine-rich glioma inactivated 4 (LGI4) protein is another candidate ligand for ADAM22 receptor. Schwann cells secrete LGI4, which through binding to the axonal receptor ADAM22 drives axonal ensheathment and myelination in the peripheral nervous system (PNS) but not central nervous system. LGI4 secretion defect results in inability of Schwann cells to correctly myelinate peripheral nerves, resulting in peripheral nervous system hypomyelination and the murine claw-paw phenotype (Birmingham et al. 2006). LGI4 interacts with not only ADAM22 but also interacts moderately with ADAM11 and ADAM23 (Ozkaynak et al. 2010, Sagane et al. 2008, Nishino et al. 2010).

Literature References
PubMed ID Title Journal Year
18974846 LGI1 and LGI4 bind to ADAM22, ADAM23 and ADAM11

Sagane, K, Ishihama, Y, Sugimoto, H

Int. J. Biol. Sci. 2008
20220021 Adam22 is a major neuronal receptor for Lgi4-mediated Schwann cell signaling

Ozkaynak, E, Abello, G, Jaegle, M, van Berge, L, Hamer, D, Kegel, L, Driegen, S, Sagane, K, Bermingham, JR, Meijer, D

J. Neurosci. 2010
Participants
Participates
Orthologous Events
Authored
Reviewed
Created
Cite Us!